88285675 - PICOBIOTICS

Information

• Trademark
• 88285675

• Source

• Serial Number

  88285675

• Registration Number

  6823397

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  February 01, 2019
  6 years ago

• Registration Date

  August 23, 2022
  2 years ago

• Transaction Date

  August 23, 2022
  2 years ago

• Status Date

  August 23, 2022
  2 years ago

• Published for Opposition Date

  June 07, 2022
  2 years ago

• Location Date

  August 23, 2022
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  STIGLITZ, SUSAN R

• Attorney Docket Number

  86291.020179

  Attorney Name

  Mark H. Tidman

  Law Office Assigned Location Code

  L90

• Owners

  • SNIPR Biome ApS

Case File Statements

• GS0051: Pharmaceutical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; medical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; veterinary preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; antibiotic preparations; pharmaceutical preparations, namely, antiviral preparations; probiotic supplements; probiotic supplements for medical use; probiotic formulations for veterinary use, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; probiotic formulations for medical use, namely, oral formulations, formulations for delivery to a microbiome in a human or animal, and formulations for delivery to skin, hair, mouth, gut, blood or a tissue, fluid or organ of a human or animal; microbiome modulators for veterinary purposes, namely, animal feed additives for use in animals feed to assist in digestion, growth or wellbeing; microbiome modulators for medical purposes, namely, as modulators of activity of pharmaceuticals in humans and animals; guided nuclease-based biocides; CRISPR-based biocides; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria
• GS0441: Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons in the nature of diagnostic and treatment counseling regarding the treatment of medical conditions and disease; pharmaceutical advice; medical and health services relating to DNA, genetics and genetic pathogen testing, namely, genetic testing for medical purposes; genetic counseling
• GS0421: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis and testing in the field of diseases and conditions associated with bacteria; industrial analysis and industrial research services; design and development of computer hardware and software; genetic microbiology and microbiome research; genetic engineering and services; design and development of hardware and software; clinical research in the field of microbes and anti-microbial medications; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibiotics; research and development of guided nuclease-based biocides; research and development of CRISPR-based biocides; research and development of CRISPR technology for the treatment of microbial diseases; medical and scientific research, namely, conducting clinical trials for others; clinical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; bacteriological research; medical and scientific research in the field of microbes and anti-microbial medications; biological research; scientific and medical screening and assaying; chemical analysis; chemical research; Medical and health services relating to DNA, genetics and genetic pathogen testing, namely, providing medical and scientific research information in the fields of pharmaceuticals and medicine

Case File Event Statements

• 8/23/2022 - 2 years ago

  42 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 8/23/2022 - 2 years ago

  41 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/7/2022 - 2 years ago

  40 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/7/2022 - 2 years ago

  39 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/18/2022 - 2 years ago

  38 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/29/2022 - 2 years ago

  37 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD

• 3/30/2022 - 2 years ago

  36 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR

• 3/15/2022 - 2 years ago

  35 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/15/2022 - 2 years ago

  34 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/15/2022 - 2 years ago

  33 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/15/2022 - 2 years ago

  32 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/15/2022 - 2 years ago

  31 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/10/2022 - 2 years ago

  30 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/10/2022 - 2 years ago

  29 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/9/2022 - 2 years ago

  28 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 9/10/2021 - 3 years ago

  27 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 9/10/2021 - 3 years ago

  26 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 9/10/2021 - 3 years ago

  25 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 8/18/2021 - 3 years ago

  24 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK

• 11/23/2020 - 4 years ago

  23 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 11/23/2020 - 4 years ago

  22 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 11/23/2020 - 4 years ago

  21 - SUSPENSION LETTER WRITTEN Type: CNSL

• 11/10/2020 - 4 years ago

  20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/10/2020 - 4 years ago

  19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/26/2020 - 4 years ago

  18 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 4/27/2020 - 4 years ago

  17 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 4/27/2020 - 4 years ago

  16 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 4/27/2020 - 4 years ago

  15 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 4/22/2020 - 4 years ago

  14 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK

• 10/15/2019 - 5 years ago

  13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 10/15/2019 - 5 years ago

  12 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 10/15/2019 - 5 years ago

  11 - SUSPENSION LETTER WRITTEN Type: CNSL

• 10/8/2019 - 5 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/8/2019 - 5 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/8/2019 - 5 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 10/2/2019 - 5 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/16/2019 - 5 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/16/2019 - 5 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 4/16/2019 - 5 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/15/2019 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/24/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 2/5/2019 - 6 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP